Stephen V Liu

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  

Stephen V Liu
Dec 22, 2024, 13:45 | Science
Details on uncommon EGFR mutations in NSCLC from Dr. Alfredo Addeo
Stephen V Liu, Associate Professor of Medicine at Georgetown University, shared a post on X:…
Dec 20, 2024, 06:58 | Science
Stephen V Liu: Will have to wait a bit longer for subcutaneous amivantamab
Stephen V Liu, Associate Professor of Medicine at Georgetown University, posted on X: "Will have…
Dec 18, 2024, 18:05 | Blog
The Adoption of the IASLC 9th Edition TNM Classification System for Lung Cancer
IASLC shared a post on X: "In this episode of Lung Cancer Considered, host Stephen…
Dec 18, 2024, 15:44 | Insight
Estela Rodriguez: New Year Resolutions - Learn a new 9th lung cancer staging system
Estela Rodriguez, Associate Director of Community Outreach and Co-Lead of Thoracic Site Disease Group of…
Dec 17, 2024, 23:14 | Science
Stephen V Liu: Resistance and identification of synthetic lethal targets in KRAS STK11 NSCLC
Stephen V Liu, Associate Professor of Medicine at Georgetown University, posted on X: "Fascinating work…
Dec 17, 2024, 19:41 | Blog
Stephen V Liu: Preclinical models of oncogenic KRAS and tumor immunity at the HTTR24 meeting
Stephen V Liu, Associate Professor of Medicine at Georgetown University, shared on X: “Dr. Miriam…
Dec 17, 2024, 13:45 | Blog
Highlights from IASLC HTTR 2024 by Stephen V Liu
HHTR 2024 took place from December 13-15, 2024, at the Hilton Washington DC National Mall…
Dec 17, 2024, 12:59 | Insight
Highlights from IASLC HTTR 2024
HHTR 2024 took place from December 13-15, 2024, at the Hilton Washington DC National Mall…
Dec 16, 2024, 18:48 | Blog
Ben Neel on resistance and identification of synthetic lethal targets in KRAS STK11 mutant NSCLC
Stephen V Liu shared on X: "Fascinating work on resistance and identification of synthetic lethal…
Dec 12, 2024, 13:21 | Blog
Stephen V Liu: Upcoming episode of the Lung Cancer Considered about staging for lung cancer and the new 9th edition TNM
Stephen V Liu, Associate Professor of Medicine at Georgetown University, shared a post on X:…
Dec 10, 2024, 14:02 | Blog
Registration is open for the Texas Lung Cancer Conference
TLC Conference posted on X: "Join us for the Texas Lung Cancer Conference, co-chaired by…
Dec 10, 2024, 04:30 | Blog
Texas Lung Cancer Conference 2025
Texas Lung Cancer Conference 2025 will be held from April 10-12, 2025 at Austin, Texas.…
Dec 2, 2024, 09:46 | Positive
Top 100 Xfluencers in Lung Cancer: Key Opinion Leaders to Follow on X (Twitter) in 2024
As November came to a close, it's an ideal time to reflect on Lung Cancer…
Nov 30, 2024, 19:38 | Insight
Stephen V Liu: Is there value in continuing osimertinib beyond progression?
Stephen V Liu, Associate Professor of Medicine at Georgetown University, shared a recent article by Tejas…
Nov 27, 2024, 19:30 | Blog
IASLC - Highlights and significant lung cancer clinical trials from 2024
IASLC shared on X: "Lung cancer breakthroughs, practice updates and key meetings made 2024 one of…
Nov 25, 2024, 17:49 | Insight
Tejas Patil: Why biomarkers like PDL1 and TMB aren’t always associated with ‘hot’ or ‘cold’ immune TME
Tejas Patil, Thoracic oncologist CU Cancer Center, shared a post by Cancer Cell on X:…
Nov 25, 2024, 14:45 | Blog
Stephen V Liu: Puneeth Iyengar reviews radiation in SCLC at MaTOS24
Stephen V Liu, Associate Professor of Medicine at Georgetown University, shared a post on X:…
Nov 25, 2024, 10:10 | Insight
Highlights from Masters in Thoracic Oncology Summit (MaTOS) 2024
2024 Masters in Thoracic Oncology Summit took place from November 21st to the 24th at…
Nov 24, 2024, 14:13 | Blog
Stephen V Liu: Current treatment for SCLC discussed by Dr. Christine Hann at MaTOS24
Stephen V Liu, Associate Professor of Medicine at Georgetown University, shared a post on X:…
Nov 24, 2024, 02:10 | Blog
Joanne Xiu: The complexity of biomarkers associated with Anti-PD-1/L1 Therapy Outcomes
Joanne Xiu, Vice President, Clinical and Translational Research at Caris Life Sciences, posted on LinkedIn…
Nov 22, 2024, 22:09 | Insight
5 papers about Lung Cancer suggested by Stephen Liu
Stephen Liu, Associate Professor at Georgetown Lombardi Comprehensive Cancer Center, shared a few must-reads papers…
Nov 21, 2024, 16:32 | Blog
The IASLC Academy is accepting applications from early career professionals in Thoracic Oncology
Stephen V Liu, Associate Professor of Medicine at Georgetown University, shared a post on X:…
Nov 19, 2024, 13:43 | Insight
Highlights from New York Lung Cancers Symposium 2024 by Stephen V Liu
The New York Lung Cancers Symposium 24 (NYLung24) took place on 16th of November 2024,…
Nov 14, 2024, 00:05 | Blog
Stephen V Liu: Federico Cappuzzo on perioperative immunotherapy at VIII Thoracic Oncology Conference
Stephen V Liu, Director of Thoracic Oncology and Head of Developmental Therapeutics at the Georgetown…
Nov 13, 2024, 16:08 | Blog
Evolving role of Radiation in early stage NSCLC by Dr. Annalisa Nardone
Stephen V Liu, Director of Thoracic Oncology and Head of Developmental Therapeutics at the Georgetown…
Nov 10, 2024, 02:12 | Blog
Applications open for the 2025 IASLC Academy
Stephen V Liu, Director of Thoracic Oncology and Head of Developmental Therapeutics and Associate Professor…
Oct 29, 2024, 10:11 | Insight
Stephen V Liu: Real-world 5-year survival with first line pembrolizumab in PD-L1 high NSCLC
Stephen V Liu, Associate Professor of Medicine at Georgetown University, shared a post on X:…
Oct 28, 2024, 14:45 | Blog
Stephen V Liu: Immunotherapy for NSCLC discussed at the Emirates Oncology Society meeting
Stephen V Liu, Associate Professor of Medicine at Georgetown University, shared a post on X:…
Oct 23, 2024, 17:34 | Insight
Episode of Lung Cancer Considered on the new management of relapsed SCLC
IASLC shared on X: “In this episode of Lung Cancer Considered, host Stephen V Liu…
Oct 22, 2024, 15:58 | Blog
Registration for the 3rd annual TexasLung25 is LIVE - TLC Conference
TLC Conference (Texas Lung Cancer Conference) shared a post on X: ''Registration for the 3rd…
Oct 22, 2024, 08:02 | Insight
Stephen V Liu: Jennifer A. Marks updates on KRAS, sotorasib and adagrasib
Stephen V Liu, Associate Professor of Medicine at Georgetown University, shared a post on X:…
Oct 22, 2024, 00:30 | Blog
Stephen V Liu: Looking forward to speaking at the lung cancer session of the 42nd CFS meeting
Stephen V Liu posted on X: "Register for the 42nd CFS meeting in New York…
Oct 21, 2024, 12:59 | Insight
Highlights from The D.C. Lung Cancer Conference 2024
The D.C. Lung Cancer Conference 2024, took place on October 19th in Washington, D.C. It…
Oct 20, 2024, 19:52 | Blog
Stephen V Liu: Case report in Annals of Oncology of patients with NUT carcinoma responding to lurbinectedin
Stephen V Liu shared a post on X, about recent case report published in Annals…
Oct 20, 2024, 17:47 | Drugs
Stephen V Liu: Long-term survival with nivolumab and ipilimumab in advanced NSCLC
Stephen V Liu shared on X: "Long-term survival (median f/u 73.7m) with nivolumab and ipilimumab…
Oct 20, 2024, 17:43 | Blog
Stephen V Liu: Huge potential utility of LB for early stage lung cancer explained by Christian Rolfo
Stephen V Liu, Associate Professor of Medicine at Georgetown University, shared on X: “Huge potential…
Oct 20, 2024, 14:51 | Blog
Stephen V Liu: Ryan Gentzler breaks down adjuvant immunotherapy for NSCLC at DCLung24
Stephen V Liu, Associate Professor of Medicine at Georgetown University, posted on X: "Dr. Ryan…
Oct 20, 2024, 13:22 | Blog
Christian Rolfo: Starting the DC Lung 2024 with the welcome by Stephen V Liu
Christian Rolfo, Division Director of Medical Oncology and Associate Director for Early Phase Clinical Trials…
Oct 18, 2024, 16:52 | Blog
Oncology Brothers: Lung Cancer Highlights from ESMO24 with Stephen V Liu
Oncology Brothers posted on X: "Lung Cancer Highlights ESMO24 with Stephen V Liu Updates on:…
Oct 17, 2024, 20:55 | Blog
Stephen V Liu: Join us at the Grand Hyatt in Washington, DC for the DC Lung Cancer Conference
Stephen V Liu posted the following on X: “Join us at the Grand Hyatt in…
Oct 16, 2024, 18:00 | Insight
Stephen V Liu: Is immunotherapy effective for HER2 mutant NSCLC?
Stephen V Liu shared on X a recent paper by Yuki Kato et al. titled…
Oct 15, 2024, 16:30 | Blog
Important ad hoc analysis of JCOG 0802 for local recurrence
Elliot Servais, Associate Professor of Surgery, UMass Chan Medical School, Tufts University School of Medicine,…
Oct 14, 2024, 13:40 | Insight
Retrospective report on EGFR mutant NSCLC transformed to SCLC, suggested by Stephen V Liu
Stephen V Liu shared a post on X: "Retrospective report in European Journal of Cancer on…
Oct 12, 2024, 17:30 | Blog
Stephen V Liu: Should patients with stage III ALK NSCLC receive adjuvant alectinib alectinib?
Stephen V Liu shared a post on X: "POLL: For patients with resected stage III…
Oct 9, 2024, 16:38 | Blog
Stephen V Liu: Case report of MET mediating resistance to entrectinib in ROS1 NSCLC
Stephen V Liu shared a post on X: "Case report of MET mediating resistance to entrectinib…
Oct 9, 2024, 09:45 | Blog
Stephen V Liu: Amin Benyounes will speak at DC Lung24 on NTRK and NRG1 fusions
Stephen V Liu shared on X: "Dr. Amin Benyounes will speak at DC Lung24 on…
Oct 8, 2024, 01:45 | Blog
Stephen V Liu: Jordi Remon discusses perioperative IO for NSCLC at ILCS24
Stephen V Liu shared a post on X: "Dr. Jordi Remon discusses perioperative IO for NSCLC…
Oct 7, 2024, 15:38 | Insight
Stephen V Liu: Afatinib and Bevacizumab in EGFR NSCLC
Stephen V Liu posted the following on X: “Phase II ABCD study of afatinib and…
Oct 7, 2024, 09:13 | Blog
Yuji Uehara: Meet the Expert session on Nov 1 at the Japan Lung Cancer Society
Yuji Uehara, Medical Oncologist, National Cancer Center, Japan, shared a post on X: "Stephen V…
Oct 6, 2024, 12:22 | Insight
Stephen V Liu: Randomized phase II trial results on amrubicin vs cisplatin for SCLC
Stephen V Liu posted the following on X: “Randomized phase II: 1L amrubicin + irinotecan…
Oct 5, 2024, 13:04 | Insight
Highlights from ILCS24 by Stephen V Liu
The 6th International Lung Cancer Summit took place as a hybrid event in Lausanne, Switzerland,…
Oct 5, 2024, 09:30 | Blog
Medicaid expansion increased use of adjuvant therapy for NSCLC
Stephen V Liu shared an article by Hamza Rshaidata on X: "In addition to developing…
Oct 4, 2024, 06:03 | Drugs
FDA approved Neoadjuvant/Adjuvant Nivolumab for resectable NSCLC
FDA Approval Introduces New Treatment Options for Adults with Resectable Lung Cancer Lacking Key Genetic…
Oct 1, 2024, 15:27 | Blog
Stephen V Liu: Eager to join the 6th International Lung Cancer Summit
Stephen V Liu posted on X: "Eager to get back to Switzerland to join the…
Oct 1, 2024, 12:28 | Societies
ASTRO 24: 15 Posts Not to Miss From Day 2
The 66th Annual Meeting of the American Society for Radiation Oncology (ASTRO) is ongoing at…
Sep 30, 2024, 15:52 | Societies
ASTRO24: 20 Posts Not To Miss From Day 1
The 66th Annual Meeting of the American Society for Radiation Oncology (ASTRO) is ongoing at…
Sep 29, 2024, 06:34 | Insight
Picks from Lung Cancer Cocktail With Science by Stephen V Liu
The Lung Cancer Cocktail With Science 2024 conference took place on September 27th in Milan,…
Sep 28, 2024, 07:13 | Blog
Stephen V Liu: Very different healthcare systems - very similar challenges and unanswered questions
Stephen V Liu shared a post on X: "Thanks to colleagues in China for a great…
Sep 27, 2024, 12:43 | Blog
Stephen V Liu: Great talks on immunotherapy and cell therapy at the 2023 Thomas Shea Clinical Cancer Symposium
Stephen V Liu shared a post on X: "Some great talks on immunotherapy and cell…
Sep 26, 2024, 15:37 | Blog
Stephen V Liu: Retrospective report on treatment post osimertinib for EGFR NSCLC
Stephen V Liu shared a post on X, about recent paper published in Clinical Lung…
Sep 26, 2024, 15:26 | Blog
Stephen V Liu: Learned a lot at the head and neck session of the Thomas Shea Symposium
Stephen V Liu shared a post on X: ''Learned a lot at the head and…
Sep 26, 2024, 14:05 | Blog
Stephen V Liu: Real-world study of first-line nivolumab and ipilimumab for pleural mesothelioma
Stephen V Liu shared a post on X, about recent paper published in Clinical Lung…
Sep 25, 2024, 14:41 | Blog
Stephen V Liu: Opening session of the 2024 Thomas Shea Clinical Cancer Symposium
Stephen V Liu posted on X: "Opening session of the 2024 Thomas Shea Clinical Cancer…
Sep 25, 2024, 14:39 | Blog
Stephen V Liu: Stephen R Broderick guides a discussion on early stage NSCLC at DCLung24
Stephen V Liu posted on X: "Stephen R Broderick guides a discussion on early stage…
Sep 24, 2024, 11:04 | Blog
Stephen V Liu: The recent FDA approval of the MARIPOSA-2 regimen for EGFR NSCLC
Stephen V Liu shared a post on X: ''In this episode of the IASLC podcast…
Sep 20, 2024, 13:27 | Blog
Stephen V Liu: FDA approved MARIPOSA2
Stephen V Liu shared on X: “FDA approved MARIPOSA2: amivantamab plus chemotherapy for EGFR NSCLC…
Sep 18, 2024, 13:28 | Blog
Stephen V Liu: An impactful ESMO24
Stephen V Liu shared on X: "An impactful ESMO24 - attending keeps you current with…
Sep 18, 2024, 09:18 | Insight
34 Posts Not to Miss From ESMO24 Day 4
The ESMO Congress 2024 took place in Barcelona, from September 13 to 17, 2024, at…
Sep 17, 2024, 15:07 | Blog
Stephen V Liu: Data from ARROS-1 study of NVL-520 in ROS1 NSCLC
Stephen V Liu shared a post on X: ''Benjamin Besse presents data from ARROS-1 study…
Sep 15, 2024, 01:34 | Insight
Some perspective on TRUST-II with talectrectinib
IASLC shared on X: “ In this episode, Narjust Florez and Stephen V Liu, recap…
Sep 14, 2024, 06:41 | Societies
Best of WCLC24
The WCLC24 took place at the San Diego Convention Center from September 7 to 10,…
Sep 12, 2024, 16:26 | Societies
35 posts not to miss from WCLC24 Day 4
The WCLC24 is took place at the San Diego Convention Center from September 7 to…
Sep 11, 2024, 16:56 | Blog
Coral Olazagasti: Honored to host the official IASLC Lung Cancer Considered podcast
Coral Olazagasti shared a post on X: "What an honor to host the official IASLC…
Sep 10, 2024, 16:09 | Societies
Highlights from WCLC24 by Stephen V Liu Part 2
The WCLC24 is taking place at the San Diego Convention Center from September 7 to…
Sep 10, 2024, 11:17 | Insight
Jennifer Marks: Our MET-working paper in collaboration with Caris Life Sciences
Jennifer Marks shared a post on X: “Our MET-working paper in collaboration with Caris Life…
Sep 10, 2024, 11:08 | Societies
Special WCLC24 Lung Cancer Considered episode
IASLC (International Association for the Study of Lung Cancer) shared a post on X: “…
Sep 10, 2024, 05:38 | Blog
WCLC24 Social Media Ambassadors
Narjust Florez shared a post on X: "Our social media ambassadors for WCLC24. Make sure…
Sep 9, 2024, 13:41 | Societies
Highlights from WCLC24 by Stephen V Liu
The WCLC24 is taking place at the San Diego Convention Center from September 7 to…
Sep 9, 2024, 09:35 | Blog
Maria Antonia Vélez: Excellent talk by Stephen V. Liu on how to give a Master Class on Scientific presentations
Maria Antonia Vélez shared a post on X: ''Excellent talk by Stephen V. Liu on…
Sep 9, 2024, 07:17 | Societies
Julie Brahmer received Paul A. Bunn Scientific Award
WCLC is a major international event focused on the latest advancements in lung cancer research,…
Sep 8, 2024, 13:51 | Societies
20 Posts Not To Miss from Day 1 of WCLC24
The International Association for the Study of Lung Cancer (IASLC) is a global, multidisciplinary organization…
Sep 8, 2024, 12:17 | Blog
Stephen V Liu: "Do You Know Your Targets" Quiz show on September 9th at WCLC24
Stephen V Liu shared a post on X: "Join us at WCLC24 on Monday, September…
Sep 5, 2024, 15:21 | Blog
Stephen V Liu: Mark your calendar for Chemotherapy Foundation Symposium 2024
Stephen V Liu shared a post on X: "With so many updates across cancer types, mark…
Sep 4, 2024, 15:28 | Blog
Hidehito Horinouchi: Early Career Investigator Workshop at WCLC24
Hidehito Horinouchi shared a post on X: ''WCLC24. Early Career Investigator Workshop. Faculties: Narjust Florez, Fabio…
Sep 1, 2024, 18:05 | Insight
Stephen Liu: The role of adjuvant chemotherapy when adjuvant ALK TKI is planned
Stephen Liu shared a post on X: "Dr. Joshua Reuss takes center stage at DC…
Aug 23, 2024, 17:15 | Blog
Brian Shields: AI evaluates recent FDA decision
Brian Shields, Creator of KOL Pulse AI, shared on LinkedIn: "AI evaluates recent FDA decision:…
Aug 23, 2024, 14:21 | Drugs
Stephen V Liu: How do we select the optimal regimen for EGFR NSCLC?
Stephen V Liu shared on X: "With FLAURA (osimertinib alone), FLAURA2 (osimertinib with chemotherapy), and…
Aug 20, 2024, 09:02 | Blog
Stephen V Liu: Join an inspiring WCLC 24 program and celebrate the IASLC 50y
Stephen V Liu shared a post on X: "Join us in 3 weeks for an inspiring…
Aug 19, 2024, 08:29 | Insight
4 leading Chinese lung cancer experts to discuss current research/clinical issues, in Mandarin - IASLC
Stephen V. Liu shared a post by IASLC on X, adding: “Thanks to Drs. Chunxia…
Aug 17, 2024, 15:47 | Blog
Stephen V Liu: Nagla Abdel Karim joins DC Lung24 to discuss targeted therapy in NSCLC
Stephen V Liu shared on X: "Dr. Nagla Abdel Karim joins DC Lung24 to guide discussions…
Aug 16, 2024, 14:13 | Insight
OS rates for IMpower133 and IMbrella A extension study in SCLC
Biagio Ricciuti shared a paper by Martin Reck et al. on X, adding: “Five-year survival…
Aug 14, 2024, 07:04 | Insight
ES-SCLC 5-year survival outcomes inIMpower133 and IMbrella study
Katsuaki Maehara, Director of Medical Education Colleagues, shared a post on X, about recent paper…
Aug 13, 2024, 09:57 | Blog
Zosia Piotrowska about what's next for EGFR at DCLung24
Stephen V Liu posted on X: "Dr. Zosia Piotrowska from MGH Thoracic Oncology will discuss…
Aug 12, 2024, 16:45 | Blog
Chul Kim on the advances in treating lung cancer with exon 20 or mutation at DCLung24
Stephen V Liu shared on X: "Dr. Chul Kim will discuss advances in treating lung…
Aug 9, 2024, 06:23 | Blog
Stephen V Liu: The current and future utility of liquid biopsy and ctDNA at DC Lung24
Stephen V Liu posted on X: "Dr. Natasha Leighl will speak at DC Lung24 on…
Aug 8, 2024, 07:50 | Insight
Narjust Florez: Amazing discussion with the leaders that made ALK + NSCLC a treatable disease
Narjust Florez shared a post by IASLC on X, adding: “Amazing discussion with the leaders…
Aug 8, 2024, 02:34 | Blog
Dr. Isabel Preeshagul will discuss perioperative targeted therapy for lung cancer at DCLung24
Stephen V Liu shared on X: “Dr. Isabel Preeshagul will discuss perioperative targeted therapy for…
Aug 7, 2024, 18:01 | Blog
Jarushka Naidoo: Survivorship in Lung Cancer, a great theme to usher in a new era in thoracic oncology
Jarushka Naidoo shared a post by LUNGevity Foundation on X, adding: "Survivorship in Lung Cancer,…
Aug 5, 2024, 14:45 | Blog
Stephen V Liu: Join me at the 19th annual New York Lung Cancers Symposium
Stephen V Liu shared on X: "Join me at the 19th annual New York Lung…
Aug 4, 2024, 06:50 | Insight
Sandip Patel joins DCLung24 with important perspective on artificial intelligence in healthcare
Stephen V Liu shared on X: "Dr. Sandip Patel joins DCLung24 with important perspective on…
12
All: 173 Posts: 1 - 100
Special Coverage